Leadership Overview
Aurobindo Pharma has 5 executives leading key functions including finance, information technology, operations, and regional management.
Driven by a commitment to global health, Aurobindo Pharma manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients, impacting diverse therapeutic areas worldwide.
Driven by a commitment to global health, Aurobindo Pharma manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients, impacting diverse therapeutic areas worldwide.
Leadership Roles at Aurobindo Pharma
Sudhir Singhi - Chief Financial Officer
Sudhir Singhi, the Chief Financial Officer at Aurobindo Pharma, directs all financial operations and strategic fiscal planning. This leadership role involves managing the company's financial health, ensuring robust capital allocation, and optimizing profitability across global markets. Singhi oversees budgeting, forecasting, and financial reporting, providing critical insights that guide executive decision-making. The Chief Financial Officer's responsibilities extend to managing investor relations and securing funding for expansion initiatives, directly supporting Aurobindo Pharma's growth objectives in generic pharmaceuticals and active pharmaceutical ingredients. By maintaining stringent financial controls and identifying new investment opportunities, Sudhir Singhi ensures the company's sustained financial stability and competitive market position. This executive's oversight is crucial for navigating complex global economic landscapes and driving value for stakeholders.
Anil Jain - Chief Operating Officer API Division
Anil Jain, the Chief Operating Officer API Division at Aurobindo Pharma, spearheads all operational aspects of the Active Pharmaceutical Ingredients (API) business. This leadership position involves managing the end-to-end production processes, ensuring the highest standards of quality and compliance in API manufacturing. Jain directs supply chain management, raw material procurement, and production scheduling to meet global demand for critical pharmaceutical components. The Chief Operating Officer API Division's focus is on optimizing manufacturing efficiency, reducing costs, and driving innovation in API development. Anil Jain's strategic oversight is fundamental to Aurobindo Pharma's ability to supply essential ingredients for a wide range of therapeutic areas, including antibiotics and anti-retrovirals. This executive's commitment to operational excellence underpins the company's reputation for reliability and quality in the global pharmaceutical market.
Arvind Chandak - President, Operations (China)
Arvind Chandak, the President, Operations (China) at Aurobindo Pharma, directs all operational activities within the significant Chinese market. This executive leadership role focuses on managing manufacturing, supply chain, and distribution networks to support Aurobindo Pharma's product portfolio in the region. Chandak oversees the strategic implementation of operational plans, ensuring compliance with local regulations and international quality standards. The President, Operations (China)'s responsibilities include driving efficiency, fostering local partnerships, and expanding market penetration for generic pharmaceuticals and active pharmaceutical ingredients. Arvind Chandak's leadership is instrumental in navigating the complexities of the Chinese pharmaceutical landscape, contributing directly to the company's global growth strategy and its mission to provide accessible healthcare solutions. This executive's regional focus is critical for sustained success in a key international market.
Chitti Babu - Group Chief Information Officer
Chitti Babu, the Group Chief Information Officer at Aurobindo Pharma, architects and executes the company's global information technology strategy. This pivotal role encompasses overseeing all digital infrastructure, cybersecurity measures, and data management systems essential for Aurobindo Pharma's manufacturing and marketing operations. Babu drives innovation in IT solutions, ensuring seamless integration of technology across all business units, from research and development to supply chain logistics. The Group Chief Information Officer's mandate includes enhancing operational efficiency through advanced technological platforms and safeguarding sensitive company data. By leading digital transformation initiatives, Chitti Babu supports the company's expansion into new therapeutic areas and strengthens its global market presence. This executive's strategic vision ensures Aurobindo Pharma remains at the forefront of technological adoption within the pharmaceutical industry.
Vijay Kondakkagari - Manager, Information Technology
Vijay Kondakkagari, the Manager, Information Technology at Aurobindo Pharma, executes critical IT support functions and system maintenance across the organization. This role involves ensuring the smooth operation of daily IT services, troubleshooting technical issues, and implementing IT policies to enhance productivity. Kondakkagari manages hardware and software installations, provides user support, and contributes to the maintenance of the company's digital infrastructure. The Manager, Information Technology's responsibilities are vital for supporting the broader IT strategy, ensuring all employees have the necessary technological resources to perform their duties effectively. Vijay Kondakkagari plays a key part in maintaining the integrity and efficiency of Aurobindo Pharma's IT environment, directly contributing to the seamless execution of business operations in manufacturing and marketing. This executive's dedication ensures reliable technology access for all departments.
Explore Leadership Teams in Manufacturing
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
Company Leadership IH
KN
AA
WS
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
Company Leadership HT
NP
MJ
Founded in 2008, Ascendis Health is a health and wellness company. They are based in Johannesburg, South Africa.
Company Leadership CN
Pv
DF
LM
Frequently Asked Questions Regarding Aurobindo Pharma Top Executives and Leadership Team
